TY - JOUR
T1 - Posterior capsular opacification and YAG laser capsulotomy in uveitis patients following cataract surgery
AU - Systemic Immunosuppressive Therapy for Eye Diseases Research Group
AU - Levy-Clarke, Grace A.
AU - Newcomb, Craig W.
AU - Ying, Gui Shuang
AU - Groth, Sylvia L.
AU - Kothari, Srishti
AU - Payal, Abhishek
AU - Begum, Hosne
AU - Liesegang, Teresa L.
AU - Foster, C. Stephen
AU - Jabs, Douglas A.
AU - Nussenblatt, Robert
AU - Rosenbaum, James T.
AU - Sen, H. Nida
AU - Suhler, Eric B.
AU - Thorne, Jennifer E.
AU - Bhatt, Nirali P.
AU - Dreger, Kurt A.
AU - Buchanich, Jeanine M.
AU - Kempen, John H.
AU - Gangaputra, Sapna
N1 - Publisher Copyright:
© 2024 Canadian Ophthalmological Society
PY - 2025/2
Y1 - 2025/2
N2 - Objective: To evaluate the incidence of visually significant posterior capsule opacification (PCO with visual acuity ≤20/50) and the incidence of Nd:YAG laser capsulotomy in the year following cataract surgery for uveitic eyes. Method: Patients were identified from the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study using a standardized chart review process. Results: Among 1,855 uveitic eyes of 1,370 patients who had undergone cataract surgery, visually significant PCO occurred in 297 eyes (16%), and YAG laser capsulotomy was done in 407 eyes (22%) within the first year following surgery. Higher odds of developing 20/50 visual acuity attributed to PCO were noted in children and young adults compared with adults older than 65 years of age (overall p = 0.03). Poorer preoperative visual acuity (overall p = 0.0069) and postoperative inflammation (odds ratio [OR] = 1.83; 95% CI, 1.37–2.45; p < 0.0001) were associated with PCO incidence. In multivariable analysis, risk factors for YAG laser capsulotomy were younger age groups compared with those older than 65 years of age at the time of surgery (adjusted OR [aOR] = 1.90–2.24; 95% CI, 1.90–2.24; overall p = 0.0007), female sex (aOR = 1.37; 95% CI, 1.03–1.82; p = 0.03), postoperative active inflammation (aOR = 165; 95% CI, 1.27–2.16; overall p < 0.0001), extracapsular cataract extraction compared with phacoemulsification (aOR = 1.70; 95% CI, 1.17–2.47; overall p < 0.0001), and insertion of an intraocular lens (aOR = 4.60; 95% CI, –2.29–9.25; p < 0.0001). Black race was associated with lower YAG laser capsulotomy incidence than Whites (aOR = 0.36; 95% CI, 0.24–0.52; overall p < 0.0001). Conclusions: Vision-reducing (≤20/50) PCO is common, occurring in about one sixth of uveitic eyes within 1 year of cataract surgery; a higher number (22%) of eyes underwent YAG laser capsulotomy within the first year. Age and postoperative inflammation following cataract surgery are the variables most associated with the incidence of visually significant PCO and YAG laser capsulotomy.
AB - Objective: To evaluate the incidence of visually significant posterior capsule opacification (PCO with visual acuity ≤20/50) and the incidence of Nd:YAG laser capsulotomy in the year following cataract surgery for uveitic eyes. Method: Patients were identified from the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study using a standardized chart review process. Results: Among 1,855 uveitic eyes of 1,370 patients who had undergone cataract surgery, visually significant PCO occurred in 297 eyes (16%), and YAG laser capsulotomy was done in 407 eyes (22%) within the first year following surgery. Higher odds of developing 20/50 visual acuity attributed to PCO were noted in children and young adults compared with adults older than 65 years of age (overall p = 0.03). Poorer preoperative visual acuity (overall p = 0.0069) and postoperative inflammation (odds ratio [OR] = 1.83; 95% CI, 1.37–2.45; p < 0.0001) were associated with PCO incidence. In multivariable analysis, risk factors for YAG laser capsulotomy were younger age groups compared with those older than 65 years of age at the time of surgery (adjusted OR [aOR] = 1.90–2.24; 95% CI, 1.90–2.24; overall p = 0.0007), female sex (aOR = 1.37; 95% CI, 1.03–1.82; p = 0.03), postoperative active inflammation (aOR = 165; 95% CI, 1.27–2.16; overall p < 0.0001), extracapsular cataract extraction compared with phacoemulsification (aOR = 1.70; 95% CI, 1.17–2.47; overall p < 0.0001), and insertion of an intraocular lens (aOR = 4.60; 95% CI, –2.29–9.25; p < 0.0001). Black race was associated with lower YAG laser capsulotomy incidence than Whites (aOR = 0.36; 95% CI, 0.24–0.52; overall p < 0.0001). Conclusions: Vision-reducing (≤20/50) PCO is common, occurring in about one sixth of uveitic eyes within 1 year of cataract surgery; a higher number (22%) of eyes underwent YAG laser capsulotomy within the first year. Age and postoperative inflammation following cataract surgery are the variables most associated with the incidence of visually significant PCO and YAG laser capsulotomy.
UR - http://www.scopus.com/inward/record.url?scp=85195501198&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85195501198&partnerID=8YFLogxK
U2 - 10.1016/j.jcjo.2024.05.004
DO - 10.1016/j.jcjo.2024.05.004
M3 - Article
C2 - 38815957
AN - SCOPUS:85195501198
SN - 0008-4182
VL - 60
SP - e124-e132
JO - Canadian Journal of Ophthalmology
JF - Canadian Journal of Ophthalmology
IS - 1
ER -